Inside the Brain: Unraveling the Mystery of Alzheimer's Disease
Published Online: Thursday, December 22, 2011
This video from National Institutes of Health’s National Institute on Aging depicts the mechanisms involved in the progression of Alzheimer’s disease and shows how the disease impacts brain activity.
The FDA has granted approval to Genzyme’s eliglustat (Cerdelga), the only first-line oral therapy for patients with Type 1 Gaucher disease.
Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy.